The zona incerta (ZI) is a subthalamic nucleus connected to several structures, some of them known to be involved with antinociception. The ZI itself may be involved with both antinociception and nociception. The antinociceptive effects of stimulating the ZI with glutamate using the rat tail-flick test and a rat model of incision pain were examined. The effects of intraperitoneal antagonists of acetylcholine, noradrenaline, serotonin, dopamine, or opioids on glutamate-induced antinociception from the ZI in the tail-flick test were also evaluated. The injection of glutamate (7 μg/0.25 μl) into the ZI increased tail-flick latency and inhibited post-incision pain, but did not change the animal performance in a Rota-rod test. The injection of glutamate into sites near the ZI was non effective. The glutamate-induced antinociception from the ZI did not occur in animals with bilateral lesion of the dorsolateral funiculus, or in rats treated intraperitoneally with naloxone (1 and 2 m/kg), methysergide (1 and 2 m/kg) or phenoxybenzamine (2 m/kg), but remained unchanged in rats treated with atropine, mecamylamine, or haloperidol (all given at doses of 1 and 2 m/kg). We conclude that the antinociceptive effect evoked from the ZI is not due to a reduced motor performance, is likely to result from the activation of a pain-inhibitory mechanism that descends to the spinal cord via the dorsolateral funiculus, and involves at least opioid, serotonergic and α-adrenergic mechanisms. This profile resembles the reported effects of these antagonists on the antinociception caused by stimulating the periaqueductal gray or the pedunculopontine tegmental nucleus.
Introduction
The zona incerta (ZI) is a subthalamic nucleus located ventrolateral to the medial lemniscus and dorsomedial to the substantia nigra (Ricardo, 1981) . Almost all major ascending and descending fiber tracts cross the ZI and target numerous brain centers from the thalamus to the spinal cord (Mitrofanis, 2005) . The ZI seems to be involved with different brain functions, such as intake of liquids and food (Gonzalez-Lima et al., 1993) , locomotion (Mogenson et al., 1985) , and sexual behavior (Edwards and Isaacs, 1991) . The ZI may also act as a diencephalic center that initiates and controls responses to a somatic or visceral stimulus and influences arousal and attention as well (Mitrofanis, 2005) .
There are evidences for the influence of the ZI on nociception and antinociception: some neurons in the ZI respond to peripheral noxious stimulation (Yen et al., 1989; Okada et al., 2002) , and their metabolic activity rises significantly during both phases of the response to intraplantar formalin (Porro et al., 2003) ; electrical stimulation of the ZI produces antinociception in the rat tail-flick test, but strong aversion was observed during the stimulation period (Prado and Roberts, 1985) .
The ZI interconnects with various brainstem nuclei, including the periaqueductal gray, pedunculopontine tegmental nucleus (PPTg) (Ricardo, 1981; Roger and Cadusseau, 1985; Shammah-Lagnado et al., 1985; Beitz, 1989; Heise and Mitrofanis, 2004) , the nucleus raphe magnus (NRM) (Erzumulu and Killackey, 1980; Ricardo, 1981; Senba et al., 1981; Peschanski, 1984; Desbois and Villanueva, 2001 ), gigantocellularis nucleus (Giα) (Watanabe and Kawana, 1982; Carlton et al., 1983) and the anterior pretectal nucleus (APtN) (Foster et al., 1989; Terenzi et al., 1995; Giber et al., 2008) , structures from which electrical stimulation evokes antinociception (Rees and Roberts, 1993; Millan, 1999) .
Stimulation-produced analgesia (SPA) from several brain structures involves the activation of descending pathways that act to inhibit noxious inputs in the spinal dorsal horn (Millan, 1999) . SPA from the NRM is mediated by serotonergic and opioid mechanisms , while SPA from Giα is mediated by neurons that project to and activate spinally projecting noradrenergic neurons located in the A7 cell group (Clark and Proudfit, 1991) . Endogenous opioids, serotonin and noradrenaline are involved in mechanisms activated during SPA from PAG (Millan, 2002) , whereas SPA from the APtN is mediated by opioid and α-adrenergic mechanisms (Rees et al., 1987) .
The present study reassessed the effects of stimulating the ZI in the rat tail-flick test. Intrinsic neurons and many crossing nerve fibers have been described in the ZI (Masri et al., 2009) , and thus stimulation of the ZI was performed using local injection of glutamate, which is known to activate cells, but not nerve fibers (Fries and Zieglgansberger, 1974) . The effects of stimulating the ZI against post-incision pain in rats were assessed as well. The effects of intraperitoneal antagonists on glutamate-induced antinociception from the ZI were also evaluated to determine whether antagonists of acetylcholine, noradrenaline, serotonin, dopamine, or opioids are effective, as they are known to be against SPA from PAG, NRM, Giα, or APtN.
Materials and methods

Animals and surgery
Experiments were carried out using male Wistar rats (150-160 g), provided by the Animal House of the University of São Paulo (USP; Campus of Ribeirão Preto). These animals were housed in groups of five per cage, and given free access to food and water throughout the experiments. The room temperature was controlled (22±1°C), and a lightdark cycle (07:00-19:00 h lights on) was maintained. (Zimmermann, 1983) were followed throughout the experiments. Each rat was used on only one occasion. Each animal was anesthetized with tribromoethanol (250 mg/kg, i.p.) and a 12-mm length of a 23-gauge stainless steel guide cannula was stereotaxically implanted into the skull until its tip lays 3 mm above the right ZI. The coordinates (in mm) were AP=+4.1(from the interaural line), L=−2.3 (from the sagittal suture), and H=−3.3 (from the skull surface). The guide cannula was fixed to the skull with two steel screws and dental cement, and kept patent with a sterile obturator until the time of drug administration. A group of rats taken for the evaluation of incision pain was contralateral or bilaterally implanted with guide cannulae in the ZI. After receiving penicillin (50 mg/kg, i.m.), the animal was allowed to recover for at least 1 week before the start of the experiments.
Microinjection procedures
Drug or saline was microinjected into the ZI using a glass needle (70-80 μm) protected by a system of telescoping steel tubes as described elsewhere (Azami et al., 1980) . The assembly was inserted into the guide cannula immediately before microinjection and the needle advanced to protrude 3 mm beyond the guide cannula tip. The injection of 2% lignocaine (0.25 μl) into the dorsal or ventral portions of the anterior pretectal nucleus significantly increased the incision pain in rats, but the effects from the different parts of the nucleus did not differ (Villarreal et al., 2004) . Therefore, the volume of solution was certainly diffusing throughout the entire nucleus. The area of the ZI (about 3 mm 2 ) is a bit larger than the area of the anterior pretectal nucleus (about 2 mm 2 ). By this reason, the volume of 0.25 μl was chosen for each injection into the ZI. This volume was delivered at a constant rate over a period of 2 min, and the needle was removed 20 s after the completion of this procedure.
Tail-flick test
Each animal was lightly restrained by hand with the tail laid across a wire coil at room temperature (23 ± 2°C). The coil temperature was then raised by the passage of an electric current and the tail-flick latency (TFL) was measured. Heat was applied to a portion of the ventral surface of the tail between 4 and 6 cm from the tip. Each trial was terminated after 6 s to minimize the probability of skin damage. TFL was measured at 5-min intervals until a stable baseline was obtained over three consecutive trials. Only rats showing stable baseline TFL after up to 6 trials were used in each experiment. The animals were then treated with intraperitoneal saline (control) or antagonist, and the TFL was measured again within 30 s and then at 5-min interval for up to 3 h after phenoxybenzamine or 15 min after the other antagonists. Glutamate or saline (0.25 μl) was then injected into the ZI, and the TFL was measured within 30 s and then at 5-min intervals for up to 15 min.
Model of incision pain
Rats were placed in an elevated clear plastic cage with a nylon mesh bottom, which allowed easy access to the paw plantar surface. Before each test, the animals remained in the cage for 15 min to allow behavioral acclimation. The baseline threshold to mechanical punctate stimulation was measured with an electronic von Frey apparatus (IITC Electronic Equipments, CA, U.S.A.), consisting of a hand-held probe unit to which a rigid plastic tip (tip area = 0.44 mm 2 ) was connected. The plastic tip was applied with increasing force in an upward direction against sites near the heel, 1-2 mm adjacent to the medial border of the wound and to similar sites in the non-incised hind paw. The movement of the probe was interrupted when a withdrawal of the stimulated paw occurred. During this procedure the applied force was continuously recorded by a main unit connected to the probe. A single trial consisted of 3 applications of the tip, once every 5 s in each hind paw. The mean of three readings was taken as the mechanical threshold for a particular timing. The animal was then anesthetized with isoflurane (in oxygen flow; 2% for induction and 0.5% for maintenance) via a loose-fitting, cone-shaped mask, and a 1-cm longitudinal incision was made with a surgical blade through the skin and fascia of the plantar aspect of the right hind paw, starting 0.5 cm from the proximal edge of the heel, as described elsewhere (Brennan et al., 1996) . The plantaris muscle was left intact during the procedure. The skin was then sutured with two 5-0 nylon stitches. The thresholds for both hind paws of each rat were measured 2 h after the incision. A solution (0.25 μl) containing saline or glutamate was then injected into the ZI contralateral to the incised paw, and the mechanical threshold for both hind paws of each animal was measured 30 s later and then at 5-min intervals for up to 25 min.
Rota-rod
The Rota-rod (Ugo Basile, Comerio, Italy) consisted of a 7-cm diameter drum rotating at 25 rpm, and was used to assess motor coordination of rats implanted 1 week earlier with a guide cannula. Each rat was placed on the drum for up to 2 min and the time of permanence was recorded on 2 occasions. An initial trial was conducted in naive rats, and the time spent by each rat on the drum was taken as baseline in the test. Twenty-four hours later, the time spent by each animal on the drum was revaluated 30 s after the injection of saline or glutamate into the ZI.
Dorsolateral funiculus lesion
Rats were initially implanted with the guide cannula directed to the ZI as described above. Two days later, they were anesthetized with tribromoethanol (250 mg/kg, i.p.), and a lesion of the dorsolateral funiculus (DLF) was made in 8 of them, bilaterally at the T1-T3 level under a surgical microscope. After laminectomy, the lesion was made by cutting a portion of the dorsolateral quadrant of the spinal cord with a sharp knife. The overlying muscles and skin were sutured, and the animal was allowed to recover for at least 5 days before the experiments. The other rats were submitted to similar procedures, except for the cord lesion, and served as sham-lesion rats. DLF-lesion rats were then injected with saline (4 animals) or glutamate (4-5 animals) in the ZI. Shamlesion rats were also injected with saline (4-5 animals) or glutamate (4-5 animals) in the ZI.
Histology
At the end of the experiments, the animal was deeply anesthetized with intraperitoneal sodium thiopental and perfused through the heart with 4% paraformaldehyde in 0.1 M phosphate buffered saline. Fast green (1%, 0.25 μl) was injected through the guide cannula to label the site of intracerebral injection. The brain was removed and the dye spot localized from 50-μm serial coronal sections stained with neutral red, and identified on diagrams from the atlas of Paxinos and Watson (1986) . The thoracic spinal cord of rats submitted to DLF lesion was removed and the extent of the lesions was also identified on diagrams from the same atlas. The ZI is anatomically divided into the rostral, dorsal, ventral and caudal sectors (Mitrofanis, 2005) , but no attempt was made to group the rats according to each sector.
Drugs
The following drugs were used: monosodium L-glutamate, atropine sulfate, mecamylamine, methysergide maleate, naloxone hydrochloride, phenoxybenzamine, and haloperidol and were purchased from Sigma (St. Louis, MO, USA). The antagonists were all prepared and diluted in saline, and their doses referred to the salt. The doses of glutamate used here (3.5 and 7.0 μg, corresponding to 23 and 47 nmol, respectively) were within the range (30-60 nmol) proposed elsewhere (Satoh et al., 1983; Jensen and Yaksh, 1989) .
Data analysis
Tail-flick latencies (in seconds) are reported as means ± SEM. Comparisons between control (rats treated in ZI and intraperitoneally with saline) and test groups were made by multivariate analysis of variance (MANOVA) with repeated measures to compare the groups over all times. The factors analyzed were treatments, time and treatment× time interaction. In the case of treatment× time interaction, one-way analysis of variance followed by Duncan's test was performed for each time. The analysis was performed using the statistical software package SPSS/PC+, version 17.0.
The changes in the animal's performance in the Rota-rod were compared using ANOVA followed by the Tukey's test. The level of significance was set at P b 0.05 in all cases.
Results
Antinociception evoked by glutamate from ZI
The groups of rats used in each experiment were not significantly different regarding baseline TFL. Rats injected with saline (0.25 μl; n = 8) into the ZI had TFL that did not differ significantly from baseline throughout the observation period. A strong increase in TFL was obtained soon after the injection of glutamate (7 μg/0.25 μl; n = 8) into the ZI, the effect remaining significantly above control for at least 5 min (Fig. 1A) . A higher dose of glutamate (14 μg/0.25 μl; n = 7) did not induce an additional effect, while a lower dose (3.5 μg/0.25 μl; n = 8) induced a non-significant increase in TFL. The curves in Fig. 1A were significantly different regarding treatment (F 3,27 = 43.62; P b 0.0001), time (F 6,162 = 116.49; P b 0.0001), and treatment × time interaction (F 18,162 = 27.59; P b 0.0001). During or after injection of glutamate, no animal showed gross disturbance of motor coordination or exhibited signs of aversion. The animals walked normally and responded to non-noxious stimulation throughout the period of observation. The location of the microinjection sites is shown in Fig. 1B . Some rats were purposely injected with glutamate (7 μg/0.25 μl) at sites near the ZI, and the results from sites in the same region were pooled and compared to that obtained from rats stimulated with glutamate in the ZI. A strong increase in TFL was confirmed for the injection into the ZI (n = 6), but not at sites neighboring the ZI (Fig. 1C) . The location of these sites is shown in Fig. 1D and includes the ventral posteromedial (n = 9) and ventral posterolateral (n = 3) thalamic nuclei, and areas lateral (n = 3) or ventral (n = 9) to the ZI.
The time course of the effects produced by the injection of saline or glutamate in the ZI on the post-incision pain is shown in Fig. 1E . The groups did not differ significantly regarding the mechanical thresholds for both hind paws measured immediately before the incision (baseline). Two hours after the incision, a reduction in the mechanical threshold of the incised paw was observed, thus characterizing the post incision pain. In contrast, no change was observed in the non-incised hind paw as compared to baseline. The post incision pain was abolished for at least 10 min after the injection of glutamate (n = 5) into the ZI contralateral to the incised paw, but remained unchanged after the injection of saline (n = 5) into the same region. The mechanical threshold of the non incised paw was not changed significantly after the injection of saline (n = 5) or glutamate (n = 5) into the ZI. The curves in Fig. 1E were significantly different regarding treatment (F 3,20 = 146.36; P b 0.0001) and time (F 10,200 = 105,45; P b 0.0001), and had significant treatment × time interaction (F 30,200 = 53.74; P b 0.0001). The location of the injection sites in the ZI is shown in Fig. 1F . The mechanical threshold of both hind paws of non incised rats was not changed significantly after the injection of saline (n = 5) or glutamate (n = 5) bilateral into the ZI (Fig. 1G) . The curves in Fig. 1G were not significantly different regarding treatment (F 3,18 = 0; P = 0.89) and time (F 6,108 = 1.06; P = 0.53), nor had significant treatment × time interaction (F 18,108 = 4.08; P = 0.3). The location of the injection sites in the ZI is shown in Fig. 1H . Representative microscope image with a dye spot restrict to the ZI is shown in Fig. 2. 
Effect of dorsolateral funiculus lesion on the antinociception evoked by glutamate from ZI
The injection of saline (0.25 μl) into the ZI of DLF-lesion (n = 5) or sham DLF-lesion (n = 4) rats did not produce significant changes in TFL regarding baseline values. A strong increase in TFL following the injection of glutamate (7 μg/0.25 μl) into the ZI was confirmed in sham (n = 5) DLF-lesion, but not in real (n = 6) DLF-lesion rats (Fig. 3A) . The curves in Fig. 3A were significantly different regarding treatment (F (3,16) = 9.43; P b 0.001), time (F (6,96) = 8.38; P b 0.001) and treatment versus time interaction (F (18,96) = 5.61; P b 0.001). The extent of the DLF lesion is shown in Fig. 3B to demonstrate that the tissue damage was restricted to the DLF and the adjacent dorsal horn. The location of the injection sites in the ZI at which glutamate induced antinociceptive effect is shown in Fig. 3C .
The injection of saline (0.25 μl) bilateral into the ZI of DLFlesion (n = 4) or sham DLF-lesion(n = 5) rats also did not produce significant changes in mechanical threshold of incised paw regarding pre incision values. The post incision pain was abolished for at least 10 min after the injection of glutamate (7 μg/0.25 μl) bilateral into the ZI of sham (n = 5) DLF-lesion, but remained unchanged after similar procedure in real (n = 5) DLF-lesion rats (Fig. 4A) . In this experiment, the mechanical threshold of non incised paws was also increased after glutamate (not shown in figures). The extent of the DLF lesion is shown in Fig. 4B and the location of the injection sites in the ZI at which glutamate induced antinociceptive effect is shown in Fig. 4C. 
Effects of injecting glutamate into the ZI on the Rota-rod performance
Two groups of 5 rats each were used in this experiment and the results are shown in Fig. 5A . The groups did not differ significantly with regard to baseline performance on the Rota-rod. Rats injected with saline (0.25 μl) had performances that did not differ significantly from baseline. Similar results were obtained with rats injected with glutamate (7 μg/0.25 μl). The data in Figs. 5A were significantly different (ANOVA: F 3,23 = 2.99; P = 0.71). The location of the injection sites in the ZI for this experiment is shown in Fig. 5B .
Effect of intraperitoneal non-selective antagonists on the glutamateinduced antinociception from ZI
Rats pretreated intraperitoneally with saline, methysergide, naloxone, phenoxybenzamine, atropine, mecamylamine, or haloperidol were injected with saline (0.25 μl) or glutamate (7 μg/0.25 μl) into the ZI. Glutamate or saline was injected into the ZI 3 h after phenoxybenzamine and 15 min after the other antagonists. No change in TFL was produced by the injection of saline into the ZI of rats treated intraperitoneally with saline (0.1 ml/kg; n = 7), compared to baseline Fig. 1 . Time course of the changes in tail-flick latency (A and C) or incision pain (E) produced by the injection (arrow) of saline (0.25 μl) or glutamate into the ZI (A and E) or at sites within or near the ZI (C). A surgical incision was performed in the plantar aspect of the right paw. The effects of the injection of saline or glutamate bilateral into the ZI on the mechanical threshold of both hind paws of non incised rats are shown in G. The doses of glutamate are given in A as μg/0.25 μl. In C, E and G, glutamate was used at a dose of 7 μg/ 0.25 μl. In E, glutamate was injected into the ZI contralateral to the incised paw. Points are means ± S.E.M. of 7-8 animals in A, 3-9 animals in C, and 5 animals in E and G. Points are different from saline-treated rats (*) or from all the other groups (#), P b 0.05. The location of injection sites for the experiments shown in A, C, E and G is shown in B, D, F and H, respectively, on diagrams taken from Paxinos and Watson (1986) . Abbreviations: VPM = ventral posteromedial thalamic nucleus; VPL = ventral posterolateral thalamic nucleus; ZI = zona incerta; RP = right paw; LP = left paw.
TFL in all cases (control). A prompt increase of TFL was obtained soon after the injection of glutamate into the ZI in saline-treated rats (n = 8), the effect being significantly higher than in control for 5 to 10 min. The effect of glutamate was fully blocked by naloxone (1 and 2 m/kg; n = 5 and 6, respectively) ( Fig. 6A ) and reduced in a dose-dependent manner by methysergide (1 and 2 mg/kg; n = 7 in both cases) (Fig. 6B) . A lower dose of naloxone (0.5 mg/kg; n = 5) or methysergide (0.5 mg/kg; n = 6) did not change the effect of glutamate ( Fig. 6A and B, respectively) . The injection of saline into the ZI of rats treated intraperitoneally with the higher dose of naloxone (n = 5) or methysergide (n = 8) did not change TFL as compared to control. The location of the sites of injection into the ZI is shown for naloxone- (Fig. 6C ), methysergide- (Fig. 6D) , and saline- (Fig. 6E ) treated rats. The curves in Fig. 6A and B were significantly different regarding treatment (F (5,30) = 9.50 and F (5,37) = 45.75, respectively; P b 0.001), time (F (8,240) = 25.75 and F (8,296) = 73.02, respectively; P b 0.0001), and treatment versus time interaction (F (40,240) = 5.47 and F (40,296) = 10.71; P b 0.0001).
Intraperitoneal phenoxybenzamine (2 mg/kg; n = 6) also significantly reduced the glutamate-induced antinociception from the ZI (Fig. 7A) . Phenoxybenzamine (0.5 and 1 mg/kg; n = 6 and 8, respectively), atropine (1 and 2 mg/kg; n = 6 in both cases), mecamylamine (1 and 2 mg/kg; n = 7 and 6, respectively), or haloperidol (1 and 2 mg/kg; n = 7 and 6, respectively), was ineffective as compared to the effect of glutamate in saline-treated rats (Fig. 7A to D,  respectively) . The injection of saline into the ZI of rats treated intraperitoneally with the higher dose of phenoxybenzamine (n = 8), atropine (n = 8), mecamylamine (n = 6) or haloperidol (n = 8) did not change TFL as compared to control. The curves in and F (32,256) = 18.87, respectively; P b 0.0001). The location of the sites of injection into the ZI in these experiments is shown in Fig. 7E to H, respectively. 
Discussion
The present study demonstrates that injection of glutamate into the ZI, but not at sites near the ZI, produces a strong but shortduration antinociception in the rat tail-flick test. The injection of glutamate into the ZI also produced analgesic effect in a rat model of incision pain. Because glutamate preferentially excites neuronal cell bodies but not fibers (Fries and Zieglgansberger, 1974) , we may conclude that increasing the activity of neuronal cells in the ZI leads to antinociception. In addition, the effect of glutamate is unlikely the result of drug spreading to structures near the ZI. Glutamatergic cells have already been shown in the ZI (Kolmac and Mitrofanis, 1999) , but parvalbumin, nitric oxide synthase, GABAergic, somatostatin, dopaminergic, enkephalinergic, calbindin D28k, and γ-melanocyte stimulating hormone-like cells have been described in the ZI as well (Mitrofanis, 2005) . Whether or not glutamate plays a physiological role as a neurotransmitter involved with antinociception in the ZI remains to be determined.
The glutamate-induced antinociception from the ZI in the tail flick test and post incision pain did not occur in animals with bilateral DLF lesions. The DLF is the main route through which most of the descending pain-inhibitory pathways travel . Therefore, the antinociceptive effect evoked from the ZI is likely to result from the activation of a pain-inhibitory mechanism that descends to the spinal cord via the DLF. The injection of glutamate into the ZI had no effect on the mechanical threshold of non incised rats. We may then conclude that mechanisms activated by glutamate from the ZI inhibit post incision pain but not non-evoked pain behavior. Masri et al. (2009) have shown that lesions of the spinal cord reduce the activity of ZI neurons. As a result, the present finding that ZI-evoked analgesia is prevented by spinal lesion might reflect the suppressed activity of ZI. However, the extent of the DLF lesion used in the present study was limited to the superficial dorsal horn, while the anterolateral quadrant of the spinal cord and the ventral and ventrolateral funiculi were targeted in Masri's experiment. Therefore, the suppressed activity of the ZI consequent to spinal lesion is unlikely to be the reason for the lack of analgesic effect of stimulating the ZI in DLF-lesion animals.
The ZI plays a role in locomotor activity and this role is supported by anatomical evidences of ZI connections with motor-related centers, such as the red nucleus, the pontine nuclei and several hypothalamic nuclei, the cervical and lumbosacral regions of the spinal cord (Mitrofanis, 2005) . We found here that the injection of glutamate into the ZI was not followed by changes of the animal performance in a Roda-rod test, which is used to assess motor changes (Dunham and Miya, 1957) . We may then conclude that the antinociceptive effect shown here is unlikely to result from a motor side effect of stimulating the ZI with glutamate.
Compared to control, the glutamate-induced antinociception from the ZI was prevented by intraperitoneal naloxone, methysergide or phenoxybenzamine (non-selective opioid, serotonergic and α-adrenergic antagonist, respectively). In contrast, intraperitoneal atropine, mecamylamine, or haloperidol (non-selective muscarinic, nicotinic, and dopaminergic antagonists, respectively) was ineffective against glutamate-induced analgesia from the ZI even though used at doses equal to or higher than those shown to be effective against chemically or electrically induced antinociception (Sahley and Berntson, 1979; Drago et al., 1984; Rees et al., 1987) . Therefore, at least, serotonergic, α-adrenergic, and endogenous opioid mechanisms but not cholinergic or dopaminergic mechanisms seem to be involved in the modulation of the glutamateinduced antinociception from the ZI. However, we cannot make conclusions about the particular site of action for each of the antagonists while using systemic antagonists.
Autoradiographic experiments showed connections from the ZI to the thalamus, hypothalamus, APtN, superior colliculus, PAG, cuneiform nucleus, red nucleus, PPTg, NRM and Giα (Watanabe and Kawana, 1982; Carlton et al., 1983) . Glutamatergic projections from the ZI to PAG (Beitz, 1989) and PPTg (Heise and Mitrofanis, 2004) have already been demonstrated. The ZI also projects to the PAG and APtN in rats (Foster et al., 1989) . The PAG (see Millan, 1999) , Fig. 7 . Changes produced by intraperitoneal (arrow 1) saline (0.1 ml/kg), phenoxybenzamine (A), atropine (B), mecamylamine (C) or haloperidol (D) on the effects of saline (0.25 μl) or glutamate (7 μg/0.25 μl) injected into the ZI of rats (arrow 2). The doses of phenoxybenzamine (pbz), atropine (atr), mecamylamine (mec), and haloperidol (hal) are given in μg/kg. The location of injection sites for the experiments shown in A to D is shown in E to H, respectively, on diagrams taken from Paxinos and Watson (1986) , and may represent more than one animal at a coincident site. The location of injection sites corresponding to groups sal/sal and sal/glu in B is the same as shown in Fig. 3E . Points are means ± S.E.M of 4 to 8 animals per group. (*) Different from control (sal/sal); (#) different from all the other groups, P b 0.05.
PPTg (Katayama et al., 1984; Iwamoto, 1989; Iwamoto and Marion, 1993) and APtN (see Rees and Roberts, 1993) are structures from which electrical stimulation evokes antinociception. ZI efferents terminating within the spinal gray matter, particularly the ventral horn, have already been demonstrated (Ricardo, 1981; Watanabe and Kawana, 1982; Peschanski et al., 1983; Roger and Cadusseau, 1985; Romanowski et al., 1985; Shammah-Lagnado et al., 1985; Shiosaka et al., 1985; Mitrofanis, 2001, 2002) .
The stimulation-produced antinociception from the PAG activates opioid and monoamine systems in the brain because naloxone and monoamine antagonists potently reduce the effects of PAG stimulation .
The SPA from the NRM is mediated by serotonergic and endogenous opioid but not noradrenergic mechanisms Azami et al., 1982) , while noradrenaline but not serotonin mediates the effect from the parabrachial nucleus and locus coeruleus (see Millan, 2002) . Giα neurons that project to and activate spinally projecting noradrenergic neurons located in the A7 cell group are involved in the mediation of the SPA from the Giα (Clark and Proudfit, 1991) .
The stimulation-induced antinociception from the PPTg is blocked by systemic naloxone, methysergide, phenoxybenzamine and atropine, but not by propranolol, haloperidol or mecamylamine (Dias et al., 2009 ). The PPTg participates as a relay station in a descending pathway from the APtN (Terenzi et al., 1992) , a brain structure from which electrical stimulation produces a strong and long-lasting antinociception, which is mediated by opioid, α-adrenergic and muscarinic cholinergic mechanisms (Rees et al., 1987) .
The injection of glutamate into the ZI inhibits the rat tail-flick reflex by mechanisms that resemble those activated by PAG or PPTg stimulation. Similarities include the effectiveness of opioid, serotonergic and α-adrenoceptor antagonists. Differing from the effect from the ZI, the SPA from the PPTg was sensitive to systemic atropine. The ZI was stimulated here with glutamate which certainly activates the brain structure in a manner more restricted than that provided by electrical stimulation, as utilized in the aforementioned studies.
Conclusions
The injection of glutamate into the rat ZI produces a strong but short-duration antinociception that does not occur in DLF-lesion rats or in rats pretreated intraperitoneally with naloxone, methysergide or phenoxybenzamine. Therefore, the effect of the ZI is likely to result from the activation of a pain-inhibitory pathway that descends to the spinal cord via the DLF and involves at least opioid, serotonergic and α-adrenergic mechanisms.
